![]() | Rheumatoid arthritis drug masitinib found effective A clinical trial of masitinib, a drug in development for the treatment of rheumatoid arthritis, has shown it to be well tolerated and effective, revealed by researchers in BioMed Central's journal Arthritis Research and Therapy. Rheumatoid arthritis - BioMed Central, UK |
![]() | Soy, tofu, sprouts can improve COPD symptoms Using soy products, like tofu, natto, bean sprouts and soy milk, can reduce the risk and symptoms of lung disease i.e. chronic obstructive pulmonary disease (COPD). Taking 75g of soy products daily is having the most health benefits and improving the lung fuction in human beings. COPD - Curtin University of Technology, Australia |
![]() | Aqua Leisure recalls inflatable baby floats The U.S. Consumer Product Safety Commission, in cooperation with the firm Aqua-Leisure Industries, of Avon, Mass., announced a voluntary recall of Inflatable Baby Floats product manufactured in China. Baby care - Consumer Product Safety Commission, USA |
![]() | Celiac disease incidence rising in US In US, Celiac disease is over four times more common today than it was 50 years ago, revealed by researchers at Mayo Clinic. The study is published in the journal Gastroenterology. Celiac disease - Mayo Clinic, USA |
![]() | Low calorie diet may slow aging A nutritious and low calorie diet blunts aging and significantly delays the onset of such age-related disorders as cancer, diabetes, cardiovascular disease and brain atrophy, revealed by researchers. Aging - University of Wisconsin-Madison, USA |
![]() | Bone density related to bone erosion in rheumatoid arthritis patients A new study has examined the relationship between two rheumatoid arthritis related processes i.e. focal erosions and osteoporosis, in the hopes of providing insight into the underlying pathophysiology of RA-related bone disease. Rheumatoid arthritis - American College of Rheumatology, USA |
![]() | Study to pinpoint bipolar disorder risk factors Around 500 Australians aged 12 to 30 will be recruited to take part in a new study to know causes of bipolar disorder and related risk factors, to be conducted in collaboration with four major research institutions in the United States - Johns Hopkins University in Baltimore and the Universities of Michigan, Indiana and Washington. Bipolar disorder - University of New South Wales, Australia |
![]() | Hormone therapy may increase ovarian cancer risk Compared with women who have never taken hormone therapy, those who currently take it or who have taken it in the past are at increased risk of ovarian cancer. Ovarian Cancer - Journal of the American Medical Association, USA |
![]() | Thalidomide does not improve survival in lung cancer Treating patients with thalidomide in combination with chemotherapy for small cell lung cancer (SCLC) did not improve their survival but did increase their risk of blood clots, revealed by researchers. Lung Cancer - Journal of the National Cancer Institute, UK |
![]() | Breast cancer drug Abraxane promising for malignant melanoma treatment An approved breast-cancer drug nab-paclitaxel, trade named Abraxane, has been found promising in clinical trial for the treatment of metastatic malignant melanoma, revealed by researchers. Melanoma - University of Arizona, USA |
![]() | Lupus drug Benlysta effective for SLE patients Human Genome Sciences, Inc. (Nasdaq: HGSI) and GlaxoSmithKline PLC (GSK) announced that BENLYSTA (belimumab, formerly LymphoStat-BŪ) met the primary endpoint in BLISS-52, the first of two pivotal Phase 3 trials in patients with serologically active systemic lupus erythematosus (SLE). Lupus - Lupus Research Institute, USA |
![]() | Designing an effective test to detect ovarian cancer Current diagnostic tests for ovarian cancer are woefully ineffective for early detection of the disease, say researchers at Stanford University School of Medicine. Ovarian Cancer - Stanford University Medical Center, USA |
![]() | Prostatectomy effective in men with aggressive prostate cancer Prostate surgery prostatectomy is found very effective in preventing death in men with aggressive prostate cancers, revealed by researchers at Memorial Sloan-Kettering Cancer Center (MSKCC), Cleveland Clinic and the University of Michigan. Prostate Cancer - Memorial Sloan-Kettering Cancer Center, USA |